Pisters KM - Search Results

1

Management of nausea and vomiting caused by anticancer drugs: state of the art.

Pisters KM, Kris MG. Pisters KM, et al. Oncology (Williston Park). 1992 Feb;6(2 Suppl):99-104. Oncology (Williston Park). 1992. PMID: 1532744 Review.

2

Midazolam in patients receiving anticancer chemotherapy and antiemetics.

Potanovich LM, Pisters KM, Kris MG, Tyson LB, Clark RA, Baltzer L, Gralla RJ. Potanovich LM, et al. Among authors: pisters km. J Pain Symptom Manage. 1993 Nov;8(8):519-24. doi: 10.1016/0885-3924(93)90080-f. J Pain Symptom Manage. 1993. PMID: 7963777 Free article. Clinical Trial.

3

Delayed emesis following anticancer chemotherapy.

Kris MG, Pisters KM, Hinkley L. Kris MG, et al. Among authors: pisters km. Support Care Cancer. 1994 Sep;2(5):297-300. doi: 10.1007/BF00365581. Support Care Cancer. 1994. PMID: 8000726 Review.

4

Randomized phase II trial comparing two versus three doses of ondansetron when used in combination with dexamethasone in patients receiving cisplatin > or = 100 mg/m2.

Tyson LB, Kris MG, Baltzer L, Pisters KM, Rigas JR, Clark RA. Tyson LB, et al. Among authors: pisters km. Am J Clin Oncol. 1994 Jun;17(3):269-72. doi: 10.1097/00000421-199406000-00018. Am J Clin Oncol. 1994. PMID: 8192116 Clinical Trial.

5

Enhancing the effectiveness of the specific serotonin antagonists. Combination antiemetic therapy with dexamethasone.

Kris MG, Baltzer L, Pisters KM, Tyson LB. Kris MG, et al. Among authors: pisters km. Cancer. 1993 Dec 1;72(11 Suppl):3436-42. doi: 10.1002/1097-0142(19931201)72:11+<3436::aid-cncr2820721610>3.0.co;2-z. Cancer. 1993. PMID: 8242576 Review.

6

The addition of ondansetron to the combination of metoclopramide, dexamethasone, and lorazepam did not improve vomiting prevention in patients receiving high-dose cisplatin.

Baltzer L, Kris MG, Tyson LB, Rigas JR, Pisters KM. Baltzer L, et al. Among authors: pisters km. Cancer. 1994 Feb 1;73(3):720-3. doi: 10.1002/1097-0142(19940201)73:3<720::aid-cncr2820730336>3.0.co;2-3. Cancer. 1994. PMID: 8299095 Clinical Trial.

7

Dose-ranging antiemetic evaluation of the serotonin antagonist RG 12915 in patients receiving anticancer chemotherapy.

Baltzer L, Kris MG, Tyson LB, Rigas JR, Vreeland F, Pisters KM. Baltzer L, et al. Among authors: pisters km. Cancer. 1993 Nov 1;72(9):2695-9. doi: 10.1002/1097-0142(19931101)72:9<2695::aid-cncr2820720928>3.0.co;2-s. Cancer. 1993. PMID: 8402492 Clinical Trial.

8

Dose-ranging antiemetic evaluation of the serotonin antagonist tropisetron in patients receiving anti-cancer chemotherapy.

Pisters KM, Kris MG, Tyson LB, Clark RA, Gralla RJ. Pisters KM, et al. Cancer. 1993 Jan 1;71(1):226-30. doi: 10.1002/1097-0142(19930101)71:1<226::aid-cncr2820710135>3.0.co;2-t. Cancer. 1993. PMID: 8416720

9

Phase II trial of a single intravenous dose of ondansetron in patients receiving cisplatin > or = 100 mg/m2.

Kris MG, Clark RA, Tyson LB, Hahne WF, Pisters KM, Gralla RJ. Kris MG, et al. Among authors: pisters km. Am J Clin Oncol. 1993 Feb;16(1):77-80. doi: 10.1097/00000421-199302000-00019. Am J Clin Oncol. 1993. PMID: 8424410 Clinical Trial.

10

Oral combination antiemetics in patients with small cell lung cancer receiving cisplatin or cyclophosphamide plus doxorubicin.

Cleri LB, Kris MG, Tyson LB, Pisters KM, Clark RA, Gralla RJ. Cleri LB, et al. Among authors: pisters km. Cancer. 1995 Sep 1;76(5):774-8. doi: 10.1002/1097-0142(19950901)76:5<774::aid-cncr2820760510>3.0.co;2-5. Cancer. 1995. PMID: 8625179 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

106 results

Search Page

Filters